Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1400 participants.

Also called NCT03304496

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 1,400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03304496
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Mexico (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT03304496. Randomized; triple masking; primary purpose supportive care. Start 2018-03-30 (actual); primary completion 2019-03-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.
Acronym
NITRAD-Sub
Intervention (Drug)
Nitroglycerin 100 MCG/ML Injectable Solution
Intervention (Drug)
Saline Solution
Lead sponsor
Instituto Nacional de Cardiologia Ignacio Chavez (class: other)

Record details

Record id
cardio:ct-nct03304496
Content hash
59e490dddbd5ef016bc3b03be010c84266eff9ef76381fc4297dc07e1bd50b93